UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate <1.8 mmol/L : HD.

Slides:

Advertisements

Similar presentations

UK Renal Registry 13th Annual Report Figure 12.1: Median height z-scores for transplant patients in 2009.

Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.

UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.

UK Renal Registry 15th Annual Report Figure 8.1. Age and gender of PD patients submitted to audit.

UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.

UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients

UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.

UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.

UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.

© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.

UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.

UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.

Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.

UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.

UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:

UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.

UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)

UK Renal Registry 16th Annual Report Figure Summary of BP achievements.

UK Renal Registry 14th Annual Report Figure Summary of BP achievements.

UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.

UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.

UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.

UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.

UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.

UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.

UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients

UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.

UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.

Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.

UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients

UK Renal Registry 9 th Annual Report 2006 Fig 14.1 Height Z scores for ERF patients aged 2 to 16 years in 2005.

UK Renal Registry 18th Annual Report

UK Renal Registry 10th Annual Report 2007

UK Renal Registry 15th Annual Report

Fig 7.1 Median URR achieved in each renal unit

UK Renal Registry 16th Annual Report

UK Renal Registry 18th Annual Report

UK Renal Registry 9th Annual Report 2006

UK Renal Registry 10th Annual Report 2007

UK Renal Registry 19th Annual Report

Peer Review Oct 2017 Haemodialysis Graphs.

CHAPTER 3 Death and Survival on Dialysis

UK Renal Registry 13th Annual Report

UK Renal Registry 11th Annual Report

UK Renal Registry 11th Annual Report 2008

UK Renal Registry 13th Annual Report

Fig 6.1 Frequency of ischaemic heart disease in incident patients

CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder

UK Renal Registry 13th Annual Report

UK Renal Registry 11th Annual Report

Renal Association UK Renal Registry.

UK Renal Registry 14th Annual Report

UK Renal Registry 16th Annual Report

ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.

Renal Association UK Renal Registry.

UK Renal Registry 12th Annual Report

UK Renal Registry 14th Annual Report

UK Renal Registry 14th Annual Report

Fig 7.1 Median URR achieved in each centre, 2006

UK Renal Registry 10th Annual Report 2007

UK Renal Registry 13th Annual Report

UK Renal Registry 16th Annual Report

Renal Association UK Renal Registry.

UK Renal Registry 11th Annual Report

UK Renal Registry 9th Annual Report 2006

Stock and Flow of Peritoneal Dialysis Patients Australia

Stock and Flow of Haemodialysis Patients Australia

Renal Association UK Renal Registry.

Presentation transcript:

UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate <1.8 mmol/L : HD

UK Renal Registry 9 th Annual Report 2006 Fig 9.2 Percentage of patients with serum phosphate <1.8mmol/L : PD

UK Renal Registry 9 th Annual Report 2006 Fig 9.3 Percentage with serum phosphate < 1.8mmol/L UK

UK Renal Registry 9 th Annual Report 2006 Fig 9.4 Median serum phosphate mmol/L: Transplant

UK Renal Registry 9 th Annual Report 2006 Fig 9.5 Funnel plot for percentage achievement of phosphate <1.8mmol/L: HD

UK Renal Registry 9 th Annual Report 2006 Fig 9.6 Percentage of patients with corrected calcium within 2.2 to 2.6 mmol/L : dialysis

UK Renal Registry 9 th Annual Report 2006 Fig 9.7 Change in percentage of patients achieving serum corrected calcium mmol/L UK

UK Renal Registry 9 th Annual Report 2006 Fig 9.8 Percentage of patients with corrected calcium within 2.2 to 2.6 mmol/L : transplant

UK Renal Registry 9 th Annual Report 2006 Fig 9.9 Median corrected calcium : transplant

UK Renal Registry 9 th Annual Report 2006 Fig 9.10 Calcium phosphate product within KDOQI ref: dialysis

UK Renal Registry 9 th Annual Report 2006 Fig 9.11 Percentage of patients with calcium phosphate product in KDOQI reference range : haemodialysis

UK Renal Registry 9 th Annual Report 2006 Fig 9.12 Percentage of patients with calcium*phosphate product in KDOQI reference range: peritoneal dialysis

UK Renal Registry 9 th Annual Report 2006 Fig 9.13 Change in percentage of patients achieving serum corrected calcium X phosphate product target UK

UK Renal Registry 9 th Annual Report 2006 Fig 9.14 Median iPTH in dialysis patients

UK Renal Registry 9 th Annual Report 2006 Fig 9.15 Percentage of patients on dialysis with iPTH < 32 pmol/L

UK Renal Registry 9 th Annual Report 2006 Fig 9.16 Percentage of patients with cholesterol < 5 mmol/L: HD

UK Renal Registry 9 th Annual Report 2006 Fig 9.17 Percentage of patients with cholesterol <= 5 mmol/L: PD

UK Renal Registry 9 th Annual Report 2006 Fig 9.18 Percentage of patients with cholesterol < 5 mmol/L: transplant

UK Renal Registry 9 th Annual Report 2006 Fig 9.19 Serum cholesterol distribution by modality 31/12/2005

UK Renal Registry 9 th Annual Report 2006 Fig 9.20 Percentage of patients with cholesterol < 5 mmol/L: HD vs PD vs Tx